Pune, India -- (SBWIRE) -- 03/24/2020 -- The Global "Intravenous Immunoglobulin Market" to reach a value of US$ 15,789.1 Mn from US$ 9,787.6 Mn. The forecast period is set from 2018 and the market is expected to grow at a CAGR of 6.2%. All information related to the market is provided in the report, titled, "Intravenous Immunoglobulin Market Size, Share and Global Trend by Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025". The rising incidence of immunodeficiency diseases in both emerging and developed nations is propelling growth of the Intravenous Immunoglobulin market.

The report covers:

Global Intravenous Immunoglobulin Market trends, with detailed analysis on consumer trends & manufacturer trends.
Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
Key areas of investments identifying market opportunities and challenges in forecast timeframe.
Competitive analysis of the industry players along with the overview on strategic management.
Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

Leading Players operating in the Intravenous Immunoglobulin Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

CSL Behring
Grifols, S.A.
Kedrion S.p.A
Octapharma
Bio Products Laboratory Ltd.
Biotest AG
China Biologic Products Holdings, Inc.
LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Increasing Cases of Hypogammaglobulinemia and Other Chronic Diseases to Boost Global Market

The increasing geriatric population and their susceptibility towards various health issues are boosting the global intravenoius immunogulobulin market. The increasing number of hemophilic patients around the world is adding to the growth of the market. This, coupoled with the prevailing number of diseases such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), and others is also fueling the demand for immunoglobuolin treatment, ultimately boosting the market.

On the flipside, the market may face challenges in terms of strict government rules and regulations with regard to the use of intravenous immunoglobulin products. In addition to this, the high risks associated with the use of these products may result in side effects and this, may further repress the growth of the market affecting its revenue globally.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Detailed Table of Content:

Introduction
1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

Executive Summary
DynamicsMarket
3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

Key Insights
4.1. Pipeline Analysis

4.2. Overview of Regulatory Scenario by Key Regions

4.3. Key Industry Developments

4.4. Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries

4.5. Overview of Reimbursement Scenario

Global Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2025
5.1. Key Findings /Summary

5.2. Market Analysis, Insights and Forecast – By Indication

5.2.1. Primary Immunodeficiency

5.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3. Guillain-Barré Syndrome (GBS)

5.2.4. Immune Thrombocytopenic Purpura (ITP)

5.2.5. Multifocal Motor Neuropathy (MMN)

5.2.6. Others

5.3. Market Analysis, Insights and Forecast – By Form

5.3.1. Liquid

5.3.2. Lyophilized

5.4. Market Analysis, Insights and Forecast – By End User

5.4.1. Hospitals

5.4.2. Clinics

5.4.3. Homecare

5.5. Market Analysis, Insights and Forecast – By Region

5.5.1. North America

5.5.2. Europe

5.5.3. Asia Pacific

5.5.4. Latin America

5.5.5. Middle East & Africa

North America Intravenous Immunoglobulin Market Analysis,Insights and Forecast, 2015-2026
6.1. Key Findings / Summary

6.2. Market Analysis – By Indication

6.2.1. Primary Immunodeficiency

6.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

6.2.3. Guillain-Barré Syndrome (GBS)

6.2.4. Immune Thrombocytopenic Purpura (ITP)

6.2.5. Multifocal Motor Neuropathy (MMN)

6.2.6. Others

6.3. Market Analysis – By Form

6.3.1. Liquid

6.3.2. Lyophilized

6.4. Market Analysis – By End User

6.4.1. Hospitals

6.4.2. Clinics

6.4.3. Homecare

6.5. Market Analysis – By Country

6.5.1. U.S.

6.5.2. Canada

Europe Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary

7.2. Market Analysis – By Indication

7.2.1. Primary Immunodeficiency

7.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

7.2.3. Guillain-Barré Syndrome (GBS)

7.2.4. Immune Thrombocytopenic Purpura (ITP)

7.2.5. Multifocal Motor Neuropathy (MMN)

7.2.6. Others

7.3. Market Analysis – By Form

7.3.1. Liquid

7.3.2. Lyophilized

7.4. Market Analysis – By End User

7.4.1. Hospitals

7.4.2. Clinics

7.4.3. Homecare

7.5. Market Analysis – By Country/ Sub-Region

7.5.1. U.K.

7.5.2. Germany

7.5.3. France

7.5.4. Spain

7.5.5. Italy

7.5.6. Scandinavia

7.5.7. Rest of Europe

Asia Pacific Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary

8.2. Market Analysis – By Indication

8.2.1. Primary Immunodeficiency

8.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

8.2.3. Guillain-Barré Syndrome (GBS)

8.2.4. Immune Thrombocytopenic Purpura (ITP)

8.2.5. Multifocal Motor Neuropathy (MMN)

8.2.6. Others

8.3. Market Analysis – By Form

8.3.1. Liquid

8.3.2. Lyophilized

8.4. Market Analysis – By End User

8.4.1. Hospitals

8.4.2. Clinics

8.4.3. Homecare

8.5. Market Analysis – By Country/ Sub-Region

8.5.1. Japan

8.5.2. China

8.5.3. India

8.5.4. Australia

8.5.5. Southeast Asia

8.5.6. Rest of Asia Pacific

Continued...

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-immunoglobulins-market-100593

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Intravenous Immunoglobulin Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates

Reasons to Purchase this Report:

Comprehensive analysis of the Intravenous Immunoglobulin Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs